Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data availability

Data will be made available on request.

Acknowledgments

The authors thank Dr. F. Lejeune (Clinique Breteche, Nantes) for harvesting the human lipoaspirates. The authors also thank all the staff at the research and investigation center (CRIP) of the Atlantic College of Veterinary Medicine (Nantes, France) for animal experiments. The authors thank V. Delplace for the synthesis of the fluorescent alginate labeled with AlexaFluor 647. The authors also thank the IBISA Micro-PICell facility (Biogenouest), a member of the national infrastructure France-Bioimaging supported by the French national research agency (ANR-10-INBS-04) for the slide scanner. The authors also acknowledge the SC3M plateform from the Inserm/NU/ONIRIS UMR1229 RMeS Laboratory and SFR François Bonamy-UMS 016. AS is a recipient of a Nanofar Erasmus Mundus Doctorate fellowship. This study was supported by grants from the Société Française de Rhumatologie (SFR), the Fondation de l'Avenir pour la Recherche Médicale Appliquée (AP-RM-18-005), the RFI Biograft program of Pays de la Loire Region within the framework of the MONOMER project, the Nantes Excellence Trajectory (NExT) funding scheme within the framework of the SHELBY project and the METAB-OA project (ANR-20-CE18-0014). Anne des Rieux is a FNRS Senior Research Associate.

Appendix A. Supplementary data

Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2023.100581.

References

[1] D.J. Hunter, D. Schofield, E. Callander, The individual and socioeconomic impact of osteoarthritis, Nat. Rev. Rheumatol. 10 (7) (2014) 437–441, https://doi.org/10.1038/nrrheum.2014.44.

[2] S.I. Hay, et al., Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet 390 (10100) (sept. 2017) 1260–1344, https://doi.org/10.1016/S0140-6736(17)32130-X.

[3] S. Safiri, et al., Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017, Ann. Rheum. Dis. 79 (6) (2020) 819–828, https://doi.org/10.1136/annrheumdis-2019-216515.

[4] D.J. Hunter, L. March, M. Chew, Osteoarthritis in 2020 and beyond: a lancet commission, Lancet 396 (10264) (nov. 2020) 1711–1712, https://doi.org/10.1016/S0140-6736(20)32230-3.

[5] D. Chen, et al., Osteoarthritis: toward a comprehensive understanding of pathological mechanism, Bone Res 5 (2017), 16044, https://doi.org/10.1038/boneres.2016.44.

[6] R.F. Loeser, S.R. Goldring, C.R. Scanzello, M.B. Goldring, Osteoarthritis: a disease of the joint as an organ, Arthritis Rheum. 64 (6) (juin 2012) 1697–1707, https://doi.org/10.1002/art.34453.

[7] J.L. Bowden, et al., Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation, Nat. Rev. Rheumatol. (juill. 2020), https://doi.org/10.1038/s41584-020-0447-8.

[8] J. Clouet, et al., From osteoarthritis treatments to future regenerative therapies for cartilage, Drug Discov. Today 14 (19–20) (oct. 2009) 913–925, https://doi.org/10.1016/j.drudis.2009.07.012.

[9] V. Delplace, M.-A. Boutet, C.L. Visage, Y. Maugars, J. Guicheux, C. Vinatier, Osteoarthritis: from upcoming treatments to treatments yet to come, Joint Bone Spine (mai 2021), 105206, https://doi.org/10.1016/j.jbspin.2021.105206.

[10] M. Ruiz, S. Cosenza, M. Maumus, C. Jorgensen, D. Noël, Therapeutic application of mesenchymal stem cells in osteoarthritis, Expet Opin. Biol. Ther. 16 (1) (2016) 33–42, https://doi.org/10.1517/14712598.2016.1093108.

[11] C. Vinatier, C. Merceron, J. Guicheux, Osteoarthritis: from pathogenic mechanisms and recent clinical developments to novel prospective therapeutic options, Drug Discov. Today 21 (12) (2016) 1932–1937, https://doi.org/10.1016/j.drudis.2016.08.011.

[12] L. Moroni, P.M. Fornasari, Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues, J. Cell. Physiol. 228 (4) (2013) 680–687, https://doi.org/10.1002/jcp.24223.

[13] M. Maumus, et al., Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis, Stem Cell Res. 11 (2) (sept. 2013) 834–844, https://doi.org/10.1016/j.scr.2013.05.008.

[14] P. Luz-Crawford, et al., Gilz-activin A as a novel signaling Axis orchestrating mesenchymal stem cell and Th17 cell interplay, Theranostics 8 (3) (janv. 2018) 846–859, https://doi.org/10.7150/thno.21793.

[15] P. Luz-Crawford, et al., Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation, Stem Cell. 34 (2) (févr. 2016) 483–492, https://doi.org/10.1002/stem.2254.

[16] H. Li, et al., Immunomodulatory functions of mesenchymal stem cells in tissue engineering, Stem Cell. Int. 2019 (2019), 9671206, https://doi.org/10.1155/2019/9671206.

[17] M. Maumus, C. Jorgensen, D. Noël, Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes, Biochimie 95 (12) (déc. 2013) 2229–2234, https://doi.org/10.1016/j.biochi.2013.04.017.

[18] U. Delling, W. Brehm, E. Ludewig, K. Winter, H. Jülke, Longitudinal evaluation of effects of intra-articular mesenchymal stromal cell administration for the treatment of osteoarthritis in an ovine model, Cell Transplant. 24 (11) (nov. 2015) 2391–2407, https://doi.org/10.3727/096368915X686193.

[19] G. Desando, et al., Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model, Arthritis Res. Ther. 15 (1) (janv. 2013) R22, https://doi.org/10.1186/ar4156.

[20] A. Guercio, et al., Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints, Cell Biol. Int. 36 (2) (2012) 189–194, https://doi.org/10.1042/CBI20110304.

[21] J.M. Murphy, D.J. Fink, E.B. Hunziker, F.P. Barry, Stem cell therapy in a caprine model of osteoarthritis, Arthritis Rheum. 48 (12) (déc. 2003) 3464–3474, https://doi.org/10.1002/art.11365.

[22] K. Toupet, et al., Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice, Arthritis Rheum. 65 (7) (juill. 2013) 1786–1794, https://doi.org/10.1002/art.37960.

[23] J.M. Lamo-Espinosa, et al., Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II), J. Transl. Med. 14 (1) (26 2016) 246, https://doi.org/10.1186/s12967-016-0998-2.

[24] Y.-M. Pers, et al., Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial, Stem Cells Transl Med 5 (7) (juill. 2016) 847–856, https://doi.org/10.5966/sctm.2015.0245.

[25] B.A. Aguado, W. Mulyasasmita, J. Su, K.J. Lampe, S.C. Heilhorn, Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers, Tissue Eng. 18 (7–8) (avr. 2012) 806–815, https://doi.org/10.1089/ten.TEA.2011.0391.

[26] O. Detante, et al., Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution, Cell Transplant. 18 (12) (2009) 1369–1379, https://doi.org/10.3727/096368909X474230.

[27] S.T. Grady, L. Britton, K. Hinrichs, A.J. Nixon, A.E. Watts, Persistence of fluorescent nanoparticle-labelled bone marrow mesenchymal stem cells in vitro and after intra-articular injection, J Tissue Eng Regen Med 13 (2) (2019) 191–202, https://doi.org/10.1002/term.2781.

[28] N. Ozeki, et al., Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats, Osteoarthritis Cartilage 24 (6) (2016) 1061–1070, https://doi.org/10.1016/j.joca.2015.12.018.

[29] K. Toupet, et al., Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis, PLoS One 10 (1) (2015) e0114962, https://doi.org/10.1371/journal.pone.0114962.

[30] C. Magri, et al., Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: a clinical pilot study, PLoS One 14 (8) (2019) e0221317, https://doi.org/10.1371/journal.pone.0221317.

[31] E.E. Mahmoud, N. Adachi, A.S. Mawas, M. Deie, M. Ochi, Multiple intra-articular injections of allogeneic bone marrow-derived stem cells potentially improve knee lesions resulting from surgically induced osteoarthritis: an animal study, Bone Joint Lett. J 101-B (7) (2019) 824–831, https://doi.org/10.1302/0301-620X.101B7.BJJ-2018-1532.R1.

[32] F. Hached, Vinatier Claire, C. LE Visage, J. Guicheux, G. Grimandi, Biomaterial-assisted cell therapy in osteoarthritis: from mesenchymal stem cells to cell encapsulation, Best Pract. Res. Clin. Rheumatol. (juin 2018), https://doi.org/10.1016/j.berh.2018.05.002.

[33] C.-Y. Lin, et al., Collagen-binding peptides for the enhanced imaging, lubrication and regeneration of osteoarthritic articular cartilage, Nat. Biomed. Eng 6 (10) (oct. 2022), https://doi.org/10.1038/s41551-022-00948-5. Art. n° 10.

[34] F. Hached, et al., Polysaccharide hydrogels support the long-term viability of encapsulated human mesenchymal stem cells and their ability to secrete immunomodulatory factors, Stem Cell. Int. 2017 (1)–11, https://doi.org/10.1155/2017/9303598.
[35] K.Y. Lee, D.J. Mooney, Alginate: properties and biomedical applications, Prog. Polym. Sci. 37 (1) (2012) 106–126, https://doi.org/10.1016/j.progpolymsci.2011.06.003 Alginate.

[36] G. Orive, et al., Cell encapsulation: technical and clinical advances, Trends Pharmacol. Sci. 36 (8) (août 2015) 537–546, https://doi.org/10.1016/j.tips.2015.05.003.

[37] H. Kim, C. Bae, Y.-M. Kook, W.-G. Koh, K. Lee, M.H. Park, Mesenchymal stem cell 3D encapsulation technologies for biomimetic microenvironment in tissue regeneration, Stem Cell Res. Ther. 10 (1) (2019) 51, https://doi.org/10.1186/s13287-018-1130-8.

[38] W. Zhang, et al., EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis, Ann. Rheum. Dis. 69 (3) (mars 2010) 483–489, https://doi.org/10.1136/ard.2009.113100.

[39] C. Merceron, et al., Pharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically oversulfated polysaccharide of marine origin: potential application to cartilage regenerative medicine, Stem Cell. 30 (3) (2012) 471–480, https://doi.org/10.1002/stem.1686.

[40] E. Mével, et al., Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption, Sci. Rep. 6 (19 2016), 33527, https://doi.org/10.1038/srep33527.

[41] S. Laverty, C.A. Girard, J.M. Williams, E.B. Hunziker, K.P.H. Pritzker, The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit, Osteoarthritis Cartilage 18 (Suppl 3) (oct. 2010) S53-S65, https://doi.org/10.1016/j.joca.2010.05.029.

[42] K.P.H. Pritzker, et al., Osteoarthritis cartilage histopathology: grading and staging, Osteoarthritis Cartilage 14 (1) (2006) 13–29, https://doi.org/10.1016/j.joca.2005.07.014.

[43] P. Bankhead, et al., QuPath: open source software for digital pathology image analysis, Sci. Rep. 7 (1) (2017), 16878, https://doi.org/10.1038/s41598-017-17204-5.

[44] J.M. McKinney, et al., Therapeutic efficacy of intra-articular delivery of encapsulated human mesenchymal stem cells on early stage osteoarthritis, Eur. Cell. Mater. 37 (janv. 2019) 42–59, https://doi.org/10.22203/eCM.v037a04.

[45] S. Khatab, et al., MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study, Cell Biol. Toxicol. 36 (6) (déc. 2020) 553–570, https://doi.org/10.1007/s10565-020-09532-6.

[46] W. Liu, H. Madry, M. Cucchiarini, Application of alginate hydrogels for next-generation articular cartilage regeneration, Int. J. Mol. Sci. 23 (3) (janv. 2022) 1147, https://doi.org/10.3390/ijms23031147.

[47] S.-M. Kang, J.-H. Lee, Y.S. Huh, S. Takayama, Alginate microencapsulation for three-dimensional in vitro cell culture, ACS Biomater. Sci. Eng. (juin 2020), https://doi.org/10.1021/acsbiomaterials.0c00457.

[48] M. Lopes, et al., Preparation methods and applications behind alginate-based particles, Expet Opin. Drug Deliv. 14 (6) (2017) 769–782, https://doi.org/10.1080/17425247.2016.1214564.

[49] B.-B. Lee, P. Ravindra, E.-S. Chan, Size and shape of calcium alginate beads produced by extrusion dripping, Chem. Eng. Technol. 36 (10) (oct. 2013) 1627–1642, https://doi.org/10.1002/ceat.201302030.

[50] V. Manojlovic, J. Djonlagic, B. Obradovic, V. Nedovic, B. Bugarski, Immobilization of cells by electrostatic droplet generation: a model system for potential application in medicine, Int. J. Nanomed. 1 (2) (jun 2006) 163–171.

[51] E.C. Stucky, R.S. Schloss, M.L. Yarmush, D.I. Shreiber, Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response, Cytotherapy 17 (10) (2015) 1353–1364, https://doi.org/10.1016/j.cytc.2015.05.002.

[52] M. Marquis, V. Alix, I. Capron, S. Cuenot, A. Zykwinska, Microfluidic encapsulation of pickering oil microdroplets into alginate microgels for lipophilic compound delivery, ACS Biomater. Sci. Eng. 2 (4) (avr. 2016) 535–543, https://doi.org/10.1021/acsbiomaterials.5b00522.

[53] L. Mazutis, R. Vasiliauskas, D.A. Weitz, Microfluidic production of alginate hydrogel particles for antibody encapsulation and release, Macromol. Biosci. 15 (12) (dec. 2015) 1641–1646, https://doi.org/10.1002/mabi.201500226.

[54] K. Messner, A. Fahlgren, J. Persliden, B.-M. Andersson, Radiographic joint space narrowing and histologic changes in a rabbit meniscectomy model of early knee osteoarthritis, Am. J. Sports Med. 29 (2) (mars 2001) 151–160, https://doi.org/10.1177/03635465010290020701.

[55] S. Selimović, J. Oh, H. Bae, M. Dokmeci, A. Khademhosseini, Microscale strategies for generating cell-encapsulating hydrogels, Polymers 4 (3) (sept. 2012) 1554.

[56] J. Yeh, et al., Micromolding of shape-controlled, harvestable cell-laden hydrogels, Biomaterials 27 (31) (nov. 2006) 5391–5398, https://doi.org/10.1016/j.biomaterials.2006.06.005.

[57] M.L. Moya, M. Morley, O. Khanna, E.C. Opara, E.M. Brey, Stability of alginate microbead properties in vitro, J. Mater. Sci. Mater. Med. 23 (2012), https://doi.org/10.1016/j.pestbp.2011.02.012 Investigations.

[58] B.F. Matlaga, L.P. Yasenchak, T.N. Salthouse, Tissue response to implanted polymers: the significance of sample shape, J. Biomed. Mater. Res. 10 (3) (1976) 391–397, https://doi.org/10.1002/jbm.820100308.

[59] J. Gao, Z. Xia, H.B. Mary, J. Joseph, J.N. Luo, Joshi, Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs, Trends Pharmacol. Sci. 43 (3) (mars 2022) 171–187, https://doi.org/10.1016/j.tips.2021.12.004.

[60] J. Jang, Y.-J. Seol, H.J. Kim, J. Kundu, S.W. Kim, D.-W. Cho, Effects of alginate hydrogel cross-linking density on mechanical and biological behaviors for tissue engineering, J. Mech. Behav. Biomed. Mater. 37 (sept. 2014) 69–77, https://doi.org/10.1016/j.jmbbm.2014.05.004.

[61] G. Kaklamani, D. Cheneler, L.M. Grover, M.J. Adams, J. Bowen, Mechanical properties of alginate hydrogels manufactured using external gelation, J. Mech. Behav. Biomed. Mater. 36 (août 2014) 135–142, https://doi.org/10.1016/j.jmbbm.2014.04.013.

[62] C.K. Kuo, P.X. Ma, Maintaining dimensions and mechanical properties of ionically crosslinked alginate hydrogel scaffolds in vitro, J. Biomed. Mater. Res., Part A 84 (4) (2008) 899–907, https://doi.org/10.1002/jbm.a.31375.

[63] F.A. Cajori, C.Y. Crouter, R. Pemberton, The physiology of synovial fluid, Arch. Intern. Med. 37 (1) (janv. 1926) 92–101, https://doi.org/10.1001/archinte.1926.00120190095008.

[64] A. Agarwal, Y. Farouz, A.P. Nesmith, L.F. Deravi, M.L. McCain, K.K. Parker, Micropatterning alginate substrates for in vitro cardiovascular muscle on a chip, Adv. Funct. Mater. 23 (30) (août 2013) 3738–3746, https://doi.org/10.1002/adfm.201203319.

[65] E. Koh, Y.C. Jung, H.-M. Woo, B.-J. Kang, Injectable alginate-microencapsulated canine adipose tissue-derived mesenchymal stem cells for enhanced viable cell retention, J. Vet. Med. Sci. 79 (3) (2017) 492–501, https://doi.org/10.1292/jvms.16-0456.

[66] M.L. Moya, et al., The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering, Biomaterials 31 (10) (avr. 2010) 2816–2826, https://doi.org/10.1016/j.biomaterials.2009.12.053.

[67] O. Veiseh, et al., Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates, Nat. Mater. 14 (6) (juin 2015) 643–651, https://doi.org/10.1038/nmat4290.

[68] P. Kalinski, Regulation of immune responses by prostaglandin E2, J. Immunol. 188 (1) (janv. 2012) 21–28, https://doi.org/10.4049/jimmunol.1101029.

[69] H. Sugimoto, S. Oda, T. Otsuki, T. Hino, T. Yoshida, Y. Shiro, Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase, Proc. Natl. Acad. Sci. U. S. A. 103 (8) (févr. 2006) 2611–2616, https://doi.org/10.1073/pnas.0508996103.

[70] I.-L. Andresen, O. Skipnes, O. Smidsrød, K. Ostgaard, P.C.H.R. Hemmer, Some biological functions of matrix components in benthic algae in relation to their chemistry and the composition of seawater, in: Cellulose Chemistry and Technology, vol. 48, American Chemical Society, 1977, pp. 361–381, https://doi.org/10.1021/bk-1977-0048.ch024.

[71] R.P. Lanza, W.M. Kühtreiber, D. Ecker, J.E. Staruk, W.L. Chick, Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres, Transplantation 59 (10) (mai 1995) 1377–1384, https://doi.org/10.1097/00007890-199505270-00003.

[72] A. Cifú, et al., The exposure to osteoarthritis synovial fluid enhances the immunomodulatory profile of adipose mesenchymal stem cell secretome, Stem Cell. Int. 2020 (2020), 4058760, https://doi.org/10.1155/2020/4058760.

[73] M.J.C. Lejis, et al., Effect of arthritic synovial fluids on the expression of immunomodulatory factors by mesenchymal stem cells: an explorative in vitro study, Front. Immunol. 3 (août 2012), https://doi.org/10.3389/fimmu.2012.00231.

[74] D.G. Malone, et al., Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells, J. Rheumatol. 21 (6) (juin 1994) 1011–1019.

[75] B.M. Campbell, E. Charych, A.W. Lee, T. Möller, Kynurenines in CNS disease: regulation by inflammatory cytokines, Front. Neurosci. 8 (12) (2014) 12, https://doi.org/10.3389/fnins.2014.000012.

[76] P.A. Walker, et al., Effect of needle diameter and flow rate on rat and human mesenchymal stromal cell characterization and viability, Tissue Eng. C Methods 16 (5) (oct. 2010) 989–997, https://doi.org/10.1089/ten.TEC.2009.0423.

[77] M.K. Mamidi, et al., Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications, J. Transl. Med. 10 (nov. 2012) 229, https://doi.org/10.1186/1479-5876-10-229.

[78] M. Yoshioka, R.D. Coutts, D. Amiel, S.A. Hacker, Characterization of a model of osteoarthritis in the rabbit knee, Osteoarthritis Cartilage 4 (2) (juin 1996) 87–98.

[79] S.M. Riester, et al., Safety studies for use of adipose tissue-derived mesenchymal stromal/stem cells in a rabbit model for osteoarthritis to support a phase I clinical trial, Stem Cells Transl Med 6 (3) (mars 2017) 910–922, https://doi.org/10.5966/sctm.2016-0097.

[80] P.J. Cope, K. Ourradi, Y. Li, M. Sharif, Models of osteoarthritis: the good, the bad and the promising, Osteoarthritis Cartilage (oct. 2018), https://doi.org/10.1016/j.joca.2018.09.016.

[81] M.H. Gregory, N. Capito, K. Kuroki, A.M. Stoker, J.L. Cook, S.L. Sherman, A review of translational animal models for knee osteoarthritis, Arthritis 2012 (2012), https://doi.org/10.1155/2012/764621.

[82] B.J. Ahern, J. Parvizi, R. Boston, T.P. Schaefer, Preclinical animal models in single site cartilage defect testing: a systematic review, Osteoarthritis Cartilage 17 (6) (juin 2009) 705–713, https://doi.org/10.1016/j.joca.2008.11.008.

[83] P. Neybecker, et al., In vitro and in vivo potentialities for cartilage repair from human advanced knee osteoarthritis synovial fluid-derived mesenchymal stem cells, Stem Cell Res. Ther. 9 (1) (nov. 2018) 329, https://doi.org/10.1186/s13287-018-1071-2.

[84] F.S. Toghraie, et al., Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit, Knee 18 (2) (mars 2011) 71–75, https://doi.org/10.1016/j.knee.2010.03.001.

[85] W. Wang, et al., Human adipose-derived mesenchymal progenitor cells engraft into rabbit articular cartilage, Int. J. Mol. Sci. 16 (6) (mai 2015) 12076–12091, https://doi.org/10.3390/ijms160612076.
[35] K.Y. Lee, D.J. Mooney, Alginate: properties and biomedical applications, Prog. Polym. Sci. 37 (1) (2012) 106–126, https://doi.org/10.1016/j.progpolymsci.2011.06.003 Alginate.

[36] G. Orive, et al., Cell encapsulation: technical and clinical advances, Trends Pharmacol. Sci. 36 (8) (août 2015) 537–546, https://doi.org/10.1016/j.tips.2015.05.003.

[37] H. Kim, C. Bae, Y.-M. Kook, W.-G. Koh, K. Lee, M.H. Park, Mesenchymal stem cell 3D encapsulation technologies for biomimetic microenvironment in tissue regeneration, Stem Cell Res. Ther. 10 (1) (2019) 51, https://doi.org/10.1186/s13287-018-1130-8.

[38] W. Zhang, et al., EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis, Ann. Rheum. Dis. 69 (3) (mars 2010) 483–489, https://doi.org/10.1136/ard.2009.113100.

[39] C. Merceron, et al., Pharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically oversulfated polysaccharide of marine origin: potential application to cartilage regenerative medicine, Stem Cell. 30 (3) (2012) 471–480, https://doi.org/10.1002/stem.1686.

[40] E. Mével, et al., Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption, Sci. Rep. 6 (19 2016), 33527, https://doi.org/10.1038/srep33527.

[41] S. Laverty, C.A. Girard, J.M. Williams, E.B. Hunziker, K.P.H. Pritzker, The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit, Osteoarthritis Cartilage 18 (Suppl 3) (oct. 2010) S53-S65, https://doi.org/10.1016/j.joca.2010.05.029.

[42] K.P.H. Pritzker, et al., Osteoarthritis cartilage histopathology: grading and staging, Osteoarthritis Cartilage 14 (1) (2006) 13–29, https://doi.org/10.1016/j.joca.2005.07.014.

[43] P. Bankhead, et al., QuPath: open source software for digital pathology image analysis, Sci. Rep. 7 (1) (2017), 16878, https://doi.org/10.1038/s41598-017-17204-5.

[44] J.M. McKinney, et al., Therapeutic efficacy of intra-articular delivery of encapsulated human mesenchymal stem cells on early stage osteoarthritis, Eur. Cell. Mater. 37 (janv. 2019) 42–59, https://doi.org/10.22203/eCM.v037a04.

[45] S. Khatab, et al., MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study, Cell Biol. Toxicol. 36 (6) (déc. 2020) 553–570, https://doi.org/10.1007/s10565-020-09532-6.

[46] W. Liu, H. Madry, M. Cucchiarini, Application of alginate hydrogels for next-generation articular cartilage regeneration, Int. J. Mol. Sci. 23 (3) (janv. 2022) 1147, https://doi.org/10.3390/ijms23031147.

[47] S.-M. Kang, J.-H. Lee, Y.S. Huh, S. Takayama, Alginate microencapsulation for three-dimensional in vitro cell culture, ACS Biomater. Sci. Eng. (juin 2020), https://doi.org/10.1021/acsbiomaterials.0c00457.

[48] M. Lopes, et al., Preparation methods and applications behind alginate-based particles, Expet Opin. Drug Deliv. 14 (6) (2017) 769–782, https://doi.org/10.1080/17425247.2016.1214564.

[49] B.-B. Lee, P. Ravindra, E.-S. Chan, Size and shape of calcium alginate beads produced by extrusion dripping, Chem. Eng. Technol. 36 (10) (oct. 2013) 1627–1642, https://doi.org/10.1002/ceat.201302030.

[50] V. Manojlovic, J. Djonlagic, B. Obradovic, V. Nedovic, B. Bugarski, Immobilization of cells by electrostatic droplet generation: a model system for potential application in medicine, Int. J. Nanomed. 1 (2) (jun 2006) 163–171.

[51] E.C. Stucky, R.S. Schloss, M.L. Yarmush, D.I. Shreiber, Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response, Cytotherapy 17 (10) (2015) 1353–1364, https://doi.org/10.1016/j.cytc.2015.05.002.

[52] M. Marquis, V. Alix, I. Capron, S. Cuenot, A. Zykwinska, Microfluidic encapsulation of pickering oil microdroplets into alginate microgels for lipophilic compound delivery, ACS Biomater. Sci. Eng. 2 (4) (avr. 2016) 535–543, https://doi.org/10.1021/acsbiomaterials.5b00522.

[53] L. Mazutis, R. Vasiliauskas, D.A. Weitz, Microfluidic production of alginate hydrogel particles for antibody encapsulation and release, Macromol. Biosci. 15 (12) (dec. 2015) 1641–1646, https://doi.org/10.1002/mabi.201500226.

[54] K. Messner, A. Fahlgren, J. Persliden, B.-M. Andersson, Radiographic joint space narrowing and histologic changes in a rabbit meniscectomy model of early knee osteoarthritis, Am. J. Sports Med. 29 (2) (mars 2001) 151–160, https://doi.org/10.1177/03635465010290020701.

[55] S. Selimović, J. Oh, H. Bae, M. Dokmeci, A. Khademhosseini, Microscale strategies for generating cell-encapsulating hydrogels, Polymers 4 (3) (sept. 2012) 1554.

[56] J. Yeh, et al., Micromolding of shape-controlled, harvestable cell-laden hydrogels, Biomaterials 27 (31) (nov. 2006) 5391–5398, https://doi.org/10.1016/j.biomaterials.2006.06.005.

[57] M.L. Moya, M. Morley, O. Khanna, E.C. Opara, E.M. Brey, Stability of alginate microbead properties in vitro, J. Mater. Sci. Mater. Med. 23 (2012), https://doi.org/10.1016/j.pestbp.2011.02.012 Investigations.

[58] B.F. Matlaga, L.P. Yasenchak, T.N. Salthouse, Tissue response to implanted polymers: the significance of sample shape, J. Biomed. Mater. Res. 10 (3) (1976) 391–397, https://doi.org/10.1002/jbm.820100308.

[59] J. Gao, Z. Xia, H.B. Mary, J. Joseph, J.N. Luo, Joshi, Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs, Trends Pharmacol. Sci. 43 (3) (mars 2022) 171–187, https://doi.org/10.1016/j.tips.2021.12.004.

[60] J. Jang, Y.-J. Seol, H.J. Kim, J. Kundu, S.W. Kim, D.-W. Cho, Effects of alginate hydrogel cross-linking density on mechanical and biological behaviors for tissue engineering, J. Mech. Behav. Biomed. Mater. 37 (sept. 2014) 69–77, https://doi.org/10.1016/j.jmbbm.2014.05.004.

[61] G. Kaklamani, D. Cheneler, L.M. Grover, M.J. Adams, J. Bowen, Mechanical properties of alginate hydrogels manufactured using external gelation, J. Mech. Behav. Biomed. Mater. 36 (août 2014) 135–142, https://doi.org/10.1016/j.jmbbm.2014.04.013.

[62] C.K. Kuo, P.X. Ma, Maintaining dimensions and mechanical properties of ionically crosslinked alginate hydrogel scaffolds in vitro, J. Biomed. Mater. Res., Part A 84 (4) (2008) 899–907, https://doi.org/10.1002/jbm.a.31375.

[63] F.A. Cajori, C.Y. Crouter, R. Pemberton, The physiology of synovial fluid, Arch. Intern. Med. 37 (1) (janv. 1926) 92–101, https://doi.org/10.1001/archinte.1926.00120190095008.

[64] A. Agarwal, Y. Farouz, A.P. Nesmith, L.F. Deravi, M.L. McCain, K.K. Parker, Micropatterning alginate substrates for in vitro cardiovascular muscle on a chip, Adv. Funct. Mater. 23 (30) (août 2013) 3738–3746, https://doi.org/10.1002/adfm.201203319.

[65] E. Koh, Y.C. Jung, H.-M. Woo, B.-J. Kang, Injectable alginate-microencapsulated canine adipose tissue-derived mesenchymal stem cells for enhanced viable cell retention, J. Vet. Med. Sci. 79 (3) (2017) 492–501, https://doi.org/10.1292/jvms.16-0456.

[66] M.L. Moya, et al., The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering, Biomaterials 31 (10) (avr. 2010) 2816–2826, https://doi.org/10.1016/j.biomaterials.2009.12.053.

[67] O. Veiseh, et al., Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates, Nat. Mater. 14 (6) (juin 2015) 643–651, https://doi.org/10.1038/nmat4290.

[68] P. Kalinski, Regulation of immune responses by prostaglandin E2, J. Immunol. 188 (1) (janv. 2012) 21–28, https://doi.org/10.4049/jimmunol.1101029.

[69] H. Sugimoto, S. Oda, T. Otsuki, T. Hino, T. Yoshida, Y. Shiro, Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase, Proc. Natl. Acad. Sci. U. S. A. 103 (8) (févr. 2006) 2611–2616, https://doi.org/10.1073/pnas.0508996103.

[70] I.-L. Andresen, O. Skipnes, O. Smidsrød, K. Ostgaard, P.C.H.R. Hemmer, Some biological functions of matrix components in benthic algae in relation to their chemistry and the composition of seawater, in: Cellulose Chemistry and Technology, vol. 48, American Chemical Society, 1977, pp. 361–381, https://doi.org/10.1021/bk-1977-0048.ch024.

[71] R.P. Lanza, W.M. Kühtreiber, D. Ecker, J.E. Staruk, W.L. Chick, Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres, Transplantation 59 (10) (mai 1995) 1377–1384, https://doi.org/10.1097/00007890-199505270-00003.

[72] A. Cifú, et al., The exposure to osteoarthritis synovial fluid enhances the immunomodulatory profile of adipose mesenchymal stem cell secretome, Stem Cell. Int. 2020 (2020), 4058760, https://doi.org/10.1155/2020/4058760.

[73] M.J.C. Lejis, et al., Effect of arthritic synovial fluids on the expression of immunomodulatory factors by mesenchymal stem cells: an explorative in vitro study, Front. Immunol. 3 (août 2012), https://doi.org/10.3389/fimmu.2012.00231.

[74] D.G. Malone, et al., Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells, J. Rheumatol. 21 (6) (juin 1994) 1011–1019.

[75] B.M. Campbell, E. Charych, A.W. Lee, T. Möller, Kynurenines in CNS disease: regulation by inflammatory cytokines, Front. Neurosci. 8 (12) (2014) 12, https://doi.org/10.3389/fnins.2014.000012.

[76] P.A. Walker, et al., Effect of needle diameter and flow rate on rat and human mesenchymal stromal cell characterization and viability, Tissue Eng. C Methods 16 (5) (oct. 2010) 989–997, https://doi.org/10.1089/ten.TEC.2009.0423.

[77] M.K. Mamidi, et al., Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications, J. Transl. Med. 10 (nov. 2012) 229, https://doi.org/10.1186/1479-5876-10-229.

[78] M. Yoshioka, R.D. Coutts, D. Amiel, S.A. Hacker, Characterization of a model of osteoarthritis in the rabbit knee, Osteoarthritis Cartilage 4 (2) (juin 1996) 87–98.

[79] S.M. Riester, et al., Safety studies for use of adipose tissue-derived mesenchymal stromal/stem cells in a rabbit model for osteoarthritis to support a phase I clinical trial, Stem Cells Transl Med 6 (3) (mars 2017) 910–922, https://doi.org/10.5966/sctm.2016-0097.

[80] P.J. Cope, K. Ourradi, Y. Li, M. Sharif, Models of osteoarthritis: the good, the bad and the promising, Osteoarthritis Cartilage (oct. 2018), https://doi.org/10.1016/j.joca.2018.09.016.

[81] M.H. Gregory, N. Capito, K. Kuroki, A.M. Stoker, J.L. Cook, S.L. Sherman, A review of translational animal models for knee osteoarthritis, Arthritis 2012 (2012), https://doi.org/10.1155/2012/764621.

[82] B.J. Ahern, J. Parvizi, R. Boston, T.P. Schaefer, Preclinical animal models in single site cartilage defect testing: a systematic review, Osteoarthritis Cartilage 17 (6) (juin 2009) 705–713, https://doi.org/10.1016/j.joca.2008.11.008.

[83] P. Neybecker, et al., In vitro and in vivo potentialities for cartilage repair from human advanced knee osteoarthritis synovial fluid-derived mesenchymal stem cells, Stem Cell Res. Ther. 9 (1) (nov. 2018) 329, https://doi.org/10.1186/s13287-018-1071-2.

[84] F.S. Toghraie, et al., Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit, Knee 18 (2) (mars 2011) 71–75, https://doi.org/10.1016/j.knee.2010.03.001.

[85] W. Wang, et al., Human adipose-derived mesenchymal progenitor cells engraft into rabbit articular cartilage, Int. J. Mol. Sci. 16 (6) (mai 2015) 12076–12091, https://doi.org/10.3390/ijms160612076.
[86] S. Choi, et al., Intra-articular injection of alginate-microencapsulated adipose tissue-derived mesenchymal stem cells for the treatment of osteoarthritis in rabbits, Stem Cell. Int. 2018 (2018), 2791632, https://doi.org/10.1155/2018/2791632.

[87] C.H. Jo, et al., Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial, Stem Cell. 32 (5) (2014) 1254–1266, https://doi.org/10.1002/stem.1634.

[88] E.-R. Chiang, H.-L. Ma, J.-P. Wang, C.-L. Liu, T.-H. Chen, S.-C. Hung, Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits, PLoS One 11 (2) (févr. 2016) e0149835, https://doi.org/10.1371/journal.pone.0149835.

[89] X. Yan, et al., Anti-friction MSCs delivery system improves the therapy for severe osteoarthritis, Adv. Mater. n/a (2021), 2104758, https://doi.org/10.1002/adma.202104758.

[90] J.H. Ketola, et al., Iterative and discrete reconstruction in the evaluation of the rabbit model of osteoarthritis, Sci. Rep. 8 (1) (2018), 12051, https://doi.org/10.1038/s41598-018-30334-8.

[91] D.L. Batiste, A. Kirkley, S. Laverty, L.M.F. Thain, A.R. Spouge, D.W. Holdsworth, Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT, Osteoarthritis Cartilage 12 (12) (déc. 2004) 986–996, https://doi.org/10.1016/j.joca.2004.08.010.

[92] T. Takebayashi, et al., Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes, JCB (J. Cell Biol.) 129 (5) (juin 1995) 1411–1419, https://doi.org/10.1083/jcb.129.5.1411.

[93] M.W. Lark, et al., Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints, J. Clin. Invest. 100 (1) (juill. 1997) 93–106, https://doi.org/10.1172/JCI19526.

[94] T. Takagi, et al., Periodic injections of adipose-derived stem cell sheets attenuate osteoarthritis progression in an experimental rabbit model, BMC Muscoskel. Disord. 21 (1) (oct. 2020) 691, https://doi.org/10.1186/s12891-020-03718-z.
[86] S. Choi, et al., Intra-articular injection of alginate-microencapsulated adipose tissue-derived mesenchymal stem cells for the treatment of osteoarthritis in rabbits, Stem Cell. Int. 2018 (2018), 2791632, https://doi.org/10.1155/2018/2791632.

[87] C.H. Jo, et al., Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial, Stem Cell. 32 (5) (2014) 1254–1266, https://doi.org/10.1002/stem.1634.

[88] E.-R. Chiang, H.-L. Ma, J.-P. Wang, C.-L. Liu, T.-H. Chen, S.-C. Hung, Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits, PLoS One 11 (2) (févr. 2016) e0149835, https://doi.org/10.1371/journal.pone.0149835.

[89] X. Yan, et al., Anti-friction MSCs delivery system improves the therapy for severe osteoarthritis, Adv. Mater. n/a (2021), 2104758, https://doi.org/10.1002/adma.202104758.

[90] J.H. Ketola, et al., Iterative and discrete reconstruction in the evaluation of the rabbit model of osteoarthritis, Sci. Rep. 8 (1) (2018), 12051, https://doi.org/10.1038/s41598-018-30334-8.

[91] D.L. Batiste, A. Kirkley, S. Laverty, L.M.F. Thain, A.R. Spouge, D.W. Holdsworth, Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT, Osteoarthritis Cartilage 12 (12) (déc. 2004) 986–996, https://doi.org/10.1016/j.joca.2004.08.010.

[92] T. Takebayashi, et al., Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes, JCB (J. Cell Biol.) 129 (5) (juin 1995) 1411–1419, https://doi.org/10.1083/jcb.129.5.1411.

[93] M.W. Lark, et al., Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints, J. Clin. Invest. 100 (1) (juill. 1997) 93–106, https://doi.org/10.1172/JCI19526.

[94] T. Takagi, et al., Periodic injections of adipose-derived stem cell sheets attenuate osteoarthritis progression in an experimental rabbit model, BMC Muscoskel. Disord. 21 (1) (oct. 2020) 691, https://doi.org/10.1186/s12891-020-03718-z.